X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Novartis with Wockhardt - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs WOCKHARDT - Comparison Results

NOVARTIS     Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

WOCKHARDT 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS WOCKHARDT NOVARTIS/
WOCKHARDT
 
P/E (TTM) x 433.9 -19.1 - View Chart
P/BV x 30.6 1.3 2,291.1% View Chart
Dividend Yield % 1.5 0.0 51,728.8%  

Financials

 NOVARTIS   WOCKHARDT
EQUITY SHARE DATA
    NOVARTIS
Mar-18
WOCKHARDT
Mar-18
NOVARTIS/
WOCKHARDT
5-Yr Chart
Click to enlarge
High Rs7581,012 74.9%   
Low Rs579532 108.9%   
Sales per share (Unadj.) Rs228.4355.9 64.2%  
Earnings per share (Unadj.) Rs31.7-60.3 -52.7%  
Cash flow per share (Unadj.) Rs32.8-46.8 -70.1%  
Dividends per share (Unadj.) Rs10.000.01 100,000.0%  
Dividend yield (eoy) %1.50 115,445.0%  
Book value per share (Unadj.) Rs297.1257.8 115.3%  
Shares outstanding (eoy) m24.69110.63 22.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.92.2 135.0%   
Avg P/E ratio x21.1-12.8 -164.5%  
P/CF ratio (eoy) x20.4-16.5 -123.6%  
Price / Book Value ratio x2.23.0 75.2%  
Dividend payout %31.50 -189,924.9%   
Avg Mkt Cap Rs m16,50585,379 19.3%   
No. of employees `0000.76.3 10.7%   
Total wages/salary Rs m1,4459,371 15.4%   
Avg. sales/employee Rs Th8,441.36,295.0 134.1%   
Avg. wages/employee Rs Th2,163.61,498.3 144.4%   
Avg. net profit/employee Rs Th1,173.1-1,066.3 -110.0%   
INCOME DATA
Net Sales Rs m5,63939,369 14.3%  
Other income Rs m1,7181,202 142.9%   
Total revenues Rs m7,35740,571 18.1%   
Gross profit Rs m-6318 -341.5%  
Depreciation Rs m251,495 1.7%   
Interest Rs m552,555 2.2%   
Profit before tax Rs m1,575-2,830 -55.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-3,582 0.0%   
Tax Rs m792257 308.0%   
Profit after tax Rs m784-6,669 -11.8%  
Gross profit margin %-1.10 -2,384.5%  
Effective tax rate %50.3-9.1 -553.3%   
Net profit margin %13.9-16.9 -82.0%  
BALANCE SHEET DATA
Current assets Rs m9,52233,796 28.2%   
Current liabilities Rs m3,29626,917 12.2%   
Net working cap to sales %110.417.5 631.9%  
Current ratio x2.91.3 230.1%  
Inventory Days Days3779 46.1%  
Debtors Days Days2889 31.9%  
Net fixed assets Rs m4639,664 0.1%   
Share capital Rs m123553 22.3%   
"Free" reserves Rs m7,21327,968 25.8%   
Net worth Rs m7,33628,522 25.7%   
Long term debt Rs m021,731 0.0%   
Total assets Rs m11,10581,620 13.6%  
Interest coverage x29.5-0.1 -27,422.7%   
Debt to equity ratio x00.8 0.0%  
Sales to assets ratio x0.50.5 105.3%   
Return on assets %7.6-5.0 -149.9%  
Return on equity %10.7-23.4 -45.7%  
Return on capital %22.2-7.7 -289.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m619,807 0.6%   
Fx outflow Rs m3,6301,789 203.0%   
Net fx Rs m-3,5708,019 -44.5%   
CASH FLOW
From Operations Rs m1,610684 235.2%  
From Investments Rs m6876,302 10.9%  
From Financial Activity Rs m-2,677-7,695 34.8%  
Net Cashflow Rs m-380-664 57.2%  

Share Holding

Indian Promoters % 0.0 74.5 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 2.0 2.3 87.0%  
FIIs % 1.6 7.7 20.8%  
ADR/GDR % 0.0 0.1 -  
Free float % 21.5 15.4 139.6%  
Shareholders   41,647 67,757 61.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   STERLING BIOTECH  SANOFI INDIA  DR. DATSONS LABS  ORCHID PHARMA LTD  GSK PHARMA  

Compare NOVARTIS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 318 Points Lower; Auto and Metal Stocks Witness Selling(Closing)

India share markets continued to witness selling pressure during closing hours and ended their day on a negative note.

Related Views on News

NOVARTIS Announces Quarterly Results (4QFY19); Net Profit Down 26.2% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, NOVARTIS has posted a net profit of Rs 195 m (down 26.2% YoY). Sales on the other hand came in at Rs 1 bn (down 11.9% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

WOCKHARDT Announces Quarterly Results (4QFY19); Net Profit Up 90.8% (Quarterly Result Update)

May 7, 2019 | Updated on May 7, 2019

For the quarter ended March 2019, WOCKHARDT has posted a net profit of Rs 139 m (up 90.8% YoY). Sales on the other hand came in at Rs 10 bn (down 3.8% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

NOVARTIS Announces Quarterly Results (3QFY19); Net Profit Down 31.3% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, NOVARTIS has posted a net profit of Rs 129 m (down 31.3% YoY). Sales on the other hand came in at Rs 1 bn (down 13.1% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

WOCKHARDT LTD. Announces Quarterly Results (3QFY19); Net Profit Down 80.6% (Quarterly Result Update)

Jan 29, 2019 | Updated on Jan 29, 2019

For the quarter ended December 2018, WOCKHARDT LTD. has posted a net profit of Rs 769 m (down 80.6% YoY). Sales on the other hand came in at Rs 10 bn (up 4.0% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

NOVARTIS Announces Quarterly Results (2QFY19); Net Profit Down 64.1% (Quarterly Result Update)

Nov 21, 2018 | Updated on Nov 21, 2018

For the quarter ended September 2018, NOVARTIS has posted a net profit of Rs 94 m (down 64.1% YoY). Sales on the other hand came in at Rs 1 bn (down 36.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

More Views on News

Most Popular

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors(The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Union Budget 2019-2020: More Style Over Substance(The 5 Minute Wrapup)

Jul 5, 2019

Did the Union Budget announce measures to stimulate the economy and bolster corporate earnings growth?

Here's What to Do with Falling Small Cap Stocks(Profit Hunter)

Jul 10, 2019

There are some great buying opportunities in the market right now - and the small cap space is your best bet.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Jul 18, 2019 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS 8-QTR ANALYSIS

COMPARE NOVARTIS WITH

MARKET STATS